3069 monitored
← Actor desksRead-only · existing recordsClassic graph view ↗

Sentinels / Actor desk

Cellectar Biosciences

person · Registry status: unverified

b52deb63-99d1-5232-bf1c-dfc5e751cccb

Evidence, not intent.

Public-source event mentions and stored signals. Adjacency does not establish causation, coordination, or an actor's position.

No claim of complete coverage or live monitoring.

Observation window

UTC dates, inclusive · maximum 90 days. Applies to events and anomalies only.

Recent observations / timeline

The source record

24 distinct events shown, newest first. Headlines may be generated summaries; inspect the source before repeating a claim.

  1. VS Pharmtech Boosts Cancer Treatment Efficacy Without Adding Toxicity – Thailand Business News

    Recorded role: co mention · WB_2299_PIPELINES

    Open source ↗
  2. Cytek Biosciences (NASDAQ:CTKB) Posts Earnings Results, Beats Estimates By $0.02 EPS

    Recorded role: co mention · WB_855_LABOR_MARKETS

    Open source ↗
  3. VS Pharmtech Boosts Cancer Treatment Efficacy Without Adding Toxicity

    Recorded role: co mention · WB_1921_PRIVATE_SECTOR_DEVELOPMENT

    Open source ↗
  4. VS Pharmtech Boosts Cancer Treatment Efficacy Without Adding Toxicity

    Recorded role: co mention · TAX_ETHNICITY_KOREAN

    Open source ↗
  5. Cytek Aurora® Evo System Wins BioTech Breakthrough Award for Drug Discovery Innovation of the Year

    Recorded role: co mention · TAX_FNCACT_LEADER

    Open source ↗
  6. Cytek Biosciences (CTKB) Q3 2026 Earnings Call Transcript - AOL

    Recorded role: co mention · TAX_ECON_PRICE

    Open source ↗
  7. Cytek Biosciences (CTKB) Q3 2026 Earnings Call Transcript | The Motley Fool

    Recorded role: co mention · TAX_FNCACT_CEO

    Open source ↗
  8. THU AM News: UW dean discusses implications of AI for research; Cellectar Biosciences rolling out new clinical trial data later this year

    Recorded role: co mention · ECON_HOUSING_PRICES

    Open source ↗
  9. Cytek Biosciences (NASDAQ:CTKB) Issues Quarterly Earnings Results

    Recorded role: co mention · WB_1921_PRIVATE_SECTOR_DEVELOPMENT

    Open source ↗
  10. Cellectar Biosciences (CLRB) Set to Release Quarterly Earnings on Tuesday

    Recorded role: co mention · TAX_FNCACT_ANALYSTS

    Open source ↗
  11. Q3 Earnings Estimate for CHRS Issued By HC Wainwright

    Recorded role: co mention · ECON_STOCKMARKET

    Open source ↗
  12. Cellectar Biosciences to Report Third Quarter Financial Results and Host a Conference Call on Tuesday, November 10, 2026

    Recorded role: co mention · TAX_DISEASE_PANCREATIC_CANCER

    Open source ↗
  13. morningstar.com: Cantor Fitzgerald Maplebear, Sean Duffy, Raymond James Baker Hughes (wb 2936 gold, wb 2936 gold)

    Recorded role: co mention · WB_2936_GOLD

    Open source ↗
  14. Coherus Oncology, Inc. (NASDAQ:CHRS) Sees Significant Decline in Short Interest

    Recorded role: co mention · TAX_DISEASE_ESOPHAGEAL_SQUAMOUS_CELL_CARCINOMA

    Open source ↗
  15. With Setara, the team behind Actio opens its second act

    Recorded role: co mention · MEDICAL

    Open source ↗
  16. Cytek Biosciences to Participate in Upcoming Investor Conferences

    Recorded role: co mention · EPU_ECONOMY_HISTORIC

    Open source ↗
  17. Biotechs buck a sluggish IPO market, but investors should tread warily

    Recorded role: co mention · TAX_ECON_PRICE

    Open source ↗
  18. Alzheimer's Disease Clinical Trial and Competitive Landscape Enters a New Phase as 200+ Companies Advance Clinical Programs | DelveInsight

    Recorded role: co mention · WB_1614_NUTRITIONAL_PROGRAMS

    Open source ↗
  19. AI-Designed Biologics Are Moving From the Screen to the Bench, and Developers Are Hiring for the Next Test

    Recorded role: co mention · SOC_INNOVATION

    Open source ↗
  20. MindWalk Holdings Corp. Strengthens Boston-Based Development Leadership as Pipeline Advances Toward Preclinical Efficacy Studies

    Recorded role: co mention · TAX_FNCACT_IMMUNOLOGIST

    Open source ↗
  21. MindWalk Holdings Corp. Strengthens Boston-Based Development Leadership as Pipeline Advances Toward Preclinical Efficacy Studies

    Recorded role: co mention · TAX_FNCACT_EXECUTIVE_OFFICER

    Open source ↗
  22. MindWalk Holdings Corp. Strengthens Boston-Based Development Leadership as Pipeline Advances Toward Preclinical Efficacy Studies

    Recorded role: co mention · WB_845_LEGAL_AND_REGULATORY_FRAMEWORK

    Open source ↗
  23. Meet the 6 brain health startups competing for $100k at BioChallenge 2026

    Recorded role: co mention · ECON_ENTREPRENEURSHIP

    Open source ↗
  24. Accord BioPharma Launches FILKRI™ (filgrastim-laha); Now Offers Both Long- and Short-Acting G-CSF Options

    Recorded role: co mention · GENERAL_HEALTH

    Open source ↗

Signals to inspect

Anomalies

Latest 10 in the selected window (up to 10). Detector output, not verified conclusions.

medium · volume spike

Volume spike: 3 events in window (3.0x baseline of 1.0 expected)

high · volume spike

Volume spike: 5 events in window (5.0x baseline of 1.0 expected)

low · volume spike

Volume spike: 2 events in window (2.0x baseline of 1.0 expected)

high · coordination signal

Coordination signal: co-actor 709832f8-c28a-576a-a271-517f31b212f4 appeared in 4 of 6 window events (67%)

critical · volume spike

Volume spike: 10 events in window (10.0x baseline of 1.0 expected)

critical · coordination signal

Coordination signal: co-actor 709832f8-c28a-576a-a271-517f31b212f4 appeared in 8 of 10 window events (80%)

medium · coordination signal

Coordination signal: co-actor 709832f8-c28a-576a-a271-517f31b212f4 appeared in 3 of 5 window events (60%)

high · new connection

New connection: 5 previously unseen co-actor(s) detected (known network: 113)

low · volume spike

Volume spike: 2 events in window (2.0x baseline of 1.0 expected)

low · new connection

New connection: 1 previously unseen co-actor(s) detected (known network: 112)

Narrative context

Unresolved threads

Latest 20 at most, across all dates. Stored narratives require human review.

No unresolved threads recorded.

Stored connections

Relationships

Up to 50 records ordered by evidence count, across all dates. Co-mentions indicate association in source material, not affiliation or coordination.

Ask this desk

Desk analyst

Read-only questions about Cellectar Biosciences's stored record. Answers cite only records retrieved for that turn; a citation chip opens the existing inspection view. Absence of matches is not evidence of inactivity.

Operator sign-in is required. Sign in

Identity is the existing actor registry record. Entity resolution and source coverage may be incomplete.